<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Leptin, a <z:chebi fb="0" ids="25905">peptide hormone</z:chebi> produced primarily by the adipocytes, is hypothesized to play a role in the pathogenesis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Soluble leptin receptor (sOB-R) may regulate leptin's physiologic functions; however its relation to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>This study explored the association of leptin and sOB-R with risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in a prospective nested case-control study within the European Prospective Investigation into <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> and Nutrition (EPIC) cohort </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 1,129 incident <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases (713 colon, 416 rectal) were matched within risk sets to 1,129 controls </plain></SENT>
<SENT sid="4" pm="."><plain>Conditional logistic regression was used to calculate relative risks (RR) and 95% confidence intervals (CI) </plain></SENT>
<SENT sid="5" pm="."><plain>After multivariable adjustment including body mass index (BMI), waist circumference, and baseline leptin concentrations, sOB-R was strongly inversely associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (RR comparing the highest quintile vs. the lowest, 0.55; 95% CI, 0.40-0.76; P(trend) = 0.0004) and <z:hpo ids='HP_0003003'>colon cancer</z:hpo> (RR, 0.42; 95% CI, 0.28-0.63, P(trend) = 0.0001); whereas no association was seen for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> (RR adjusted for BMI and waist circumference, 0.83; 95% CI, 0.48-1.44, P(trend) = 0.38) </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, leptin was not associated with risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> (RR adjusted for BMI and waist circumference, 0.85; 95% CI, 0.56-1.29, P(trend) = 0.23) </plain></SENT>
<SENT sid="7" pm="."><plain>Additional adjustments for circulating metabolic biomarkers did not attenuate these results </plain></SENT>
<SENT sid="8" pm="."><plain>These novel findings suggest a strong inverse association between circulating sOB-R and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk, independent of <z:hpo ids='HP_0001513'>obesity</z:hpo> measures, leptin concentrations, and other metabolic biomarkers </plain></SENT>
<SENT sid="9" pm="."><plain>Further research is needed to confirm the potentially important role of sOB-R in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> pathogenesis </plain></SENT>
</text></document>